{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:51:46Z","timestamp":1791661906754,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biopha.2022.113615","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T18:28:18Z","timestamp":1661970498000},"page":"113615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Already low drug dose antagonism of the renin-angiotensin aldosterone system decreases 1-year mortality and rehospitalization in old heart failure patients"],"prefix":"10.1016","volume":"154","author":[{"given":"N.","family":"Soborun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Abdurashidova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tzimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schukraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Hugli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vollenweider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Monney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113615_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2022.113615_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5892","article-title":"Association of the mineralocorticoid receptor antagonist use with all-cause mortality and hospital readmission in older adults with acute decompensated heart failure","volume":"2","author":"Yaku","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.biopha.2022.113615_bib3","first-page":"6","article-title":"Prognostic significance of an early echocardiographic evaluation of right ventricular dimension and function in acute heart failure","author":"Palazzuoli","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib4","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1002\/ehf2.12983","article-title":"Non-severe aortic regurgitation increases short-term mortality in acute heart failure with preserved ejection fraction","volume":"7","author":"Abdurashidova","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"42","key":"10.1016\/j.biopha.2022.113615_bib5","first-page":"1","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"2021","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.113615_bib6","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with preserved ejection fraction","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113615_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ehf2.12091","article-title":"Red cell distribution width and mortality in acute heart failure patients with preserved and reduced ejection fraction","volume":"3","author":"Sotiropoulos","year":"2016","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib8","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","article-title":"Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study","volume":"38","author":"Ouwerkerk","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.113615_bib9","first-page":"13","article-title":"Contemporary drug treatment of chronic heart failure with reduced ejection fraction","volume":"7","author":"Brunner La Rocca","year":"2019","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12877-019-1215-y","article-title":"National survey on the management of heart failure in individuals over 80 years of age in French geriatric care centers","volume":"19","author":"Boully","year":"2019","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.biopha.2022.113615_bib11","first-page":"611","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European association of cardiovascular imaging","volume":"14","author":"Lancelotti","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.113615_bib12","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39,372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.113615_bib13","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics \u2013 2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.113615_bib14","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/ejhf.1594","article-title":"Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis","volume":"21","author":"Jones","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ejhf.162","article-title":"Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry","volume":"16","author":"Lund","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib16","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1001\/archinte.162.15.1682","article-title":"Representation of the elderly, women, and minorities in heart failure clinical trials","volume":"162","author":"Heiat","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.biopha.2022.113615_bib17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurjhf\/hfr020","article-title":"Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial","volume":"13","author":"D\u00fcngen","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.113615_bib19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure","volume":"316","author":"The Consensus Trial Study Group","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113615_bib20","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/ejhf.2064","article-title":"Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR preserved trial","volume":"22","author":"Anker","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib21","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction","volume":"70","author":"Haolin","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2022.113615_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cardfail.2021.04.015","article-title":"Association between betablockers and outcomes in heart failure with preserved ejection fraction: current insight from the SwedeHF registry","volume":"27","author":"Meyer","year":"2021","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10741-017-9598-3","article-title":"Heart failure in the elderly: ten peculiar management considerations","volume":"22","author":"Bader","year":"2017","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2022.113615_bib24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2022.113615_bib25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00392-020-01607-y","article-title":"Medical treatment of octogenerians with chronic heart failure: data from the CHECK-HF","volume":"109","author":"Linssen","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.biopha.2022.113615_bib26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/eurheartj\/ehn539","article-title":"Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro heart failure survey II","volume":"30","author":"Komajda","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.113615_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ejhf.1799","article-title":"Heart failure treatment uptitration and outcome and age: an analysis of BIOSTAT-CHF","volume":"23","author":"Mordi","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.13223","article-title":"Adherence and optimization of angiotensin converting inhibitor\/angiotensin II receptor blockers and beta-blockers in patients hospitalized for acute heart failure","author":"Carubelli","year":"2021","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib29","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.113615_bib30","article-title":"Effectiveness of guidelines-consistent heart failure drug prescriptions at hospital discharge on 1-year mortality: results from the EPICAL 2 cohort study","author":"Busson","year":"2017","journal-title":"Eur. J. Int. Med."},{"key":"10.1016\/j.biopha.2022.113615_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ejhf.932","article-title":"Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study","volume":"20","author":"Gayat","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2022.113615_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.104.527549","article-title":"Adoption of spironolactone therapy for older patients with heart failure and left ventricular dysfunction in the United States, 1998\u20132001","volume":"112","author":"Masoudi","year":"2005","journal-title":"Circulation"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:39:16Z","timestamp":1791661156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222010046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"alternative-id":["S0753332222010046"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113615","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Already low drug dose antagonism of the renin-angiotensin aldosterone system decreases 1-year mortality and rehospitalization in old heart failure patients","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113615"}}